{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T12:28:25Z","timestamp":1787228905584,"version":"build-2736575974"},"reference-count":95,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>Bladder cancer is a prevalent urinary malignancy with high global incidence and mortality. Despite advances in diagnosis and treatment, challenges persist, particularly due to high recurrence rates and unpredictable progression. Recent evidence highlights the role of urinary tract microbiota in BC initiation, progression, and recurrence. The urinary tract, once thought sterile, is now recognized as a complex microbial environment influencing local immunity and carcinogenesis. Differences in microbiota composition between cancer patients and controls, as well as variations by gender, age, and lifestyle factors like smoking, have been observed. The microbiota may impact tumor staging, grading, recurrence, and treatment responses, particularly to Bacillus Calmette-Gu\u00e9rin therapy. Mechanisms include immune modulation, inflammation, and epithelial barrier disruption. This review synthesizes current research on urinary microbiota\u2019s role in BC, emphasizing its potential as a biomarker and therapeutic target. Large-scale studies are needed to better understand these associations and develop microbiota-based strategies for improved BC management.<\/jats:p>","DOI":"10.3389\/fcimb.2026.1890640","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T12:01:41Z","timestamp":1787227301000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Urinary microbiota in bladder cancer: insights into pathogenesis, diagnosis, and therapeutic potential"],"prefix":"10.3389","volume":"16","author":[{"given":"Zhaoyang","family":"Sheng","sequence":"first","affiliation":[{"name":"Department of Urology, Shanghai Changhai Hospital, Naval Medical University","place":["Shanghai, China"]},{"name":"Department of Urology, The 904th Hospital, Joint Logistics Support Force","place":["Wuxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinpeng","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Urology, Shanghai Changhai Hospital, Naval Medical University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianming","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Urology, The 904th Hospital, Joint Logistics Support Force","place":["Wuxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ShuXiong","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Urology, Shanghai Changhai Hospital, Naval Medical University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Urology, The 904th Hospital, Joint Logistics Support Force","place":["Wuxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZhenSheng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Urology, Shanghai Changhai Hospital, Naval Medical University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1097\/gco.0000000000000747","article-title":"The bladder microbiome and interstitial cystitis: is there a connection","volume":"33","author":"Abernethy","year":"2021","journal-title":"Curr. Opin. Obstetrics Gynecology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/nrurol.2015.292","article-title":"The interplay of extracellular matrix and microbiome in urothelial bladder cancer","volume":"13","author":"Alfano","year":"2016","journal-title":"Nat. Rev. Urol."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5284754","article-title":"Colonic mucosal microbiota in colorectal cancer: a single-center metagenomic study in Saudi Arabia","volume":"2018","author":"Alomair","year":"2018","journal-title":"Gastroent Res. Pract."},{"key":"B4","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/978-3-030-34025-4_5","article-title":"Gut microbiota and cancer of the host: colliding interests","volume":"1219","author":"Baffy","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.euf.2018.08.001","article-title":"Male bladder microbiome relates to lower urinary tract symptoms","volume":"6","author":"Bajic","year":"2020","journal-title":"Eur. Urol. Focus"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1096\/fj.12-227074","article-title":"Genotoxicity of tobacco smoke-derived aromatic amines and bladder cancer: current state of knowledge and future research directions","volume":"27","author":"Besaratinia","year":"2013","journal-title":"FASEB J."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/s1569-9056(19)31053-x","article-title":"Urinary microbiota-a potential biomarker and therapeutic target for bladder cancer","volume":"26","author":"Bi","year":"2019","journal-title":"Int. J. Urol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1099\/jmm.0.001058","article-title":"Urinary microbiota \u2013 a potential biomarker and therapeutic target for bladder cancer","volume":"68","author":"Bi","year":"2019","journal-title":"J. Med. Microbiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1099\/jmm.0.001058","article-title":"Urinary microbiota - a potential biomarker and therapeutic target for bladder cancer","volume":"68","author":"Bi","year":"2019","journal-title":"J. Med. Microbiol."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2025.1479795","article-title":"Urinary microbiota changes among NMIBC patients during BCG therapy: comparing BCG responders and non-responders","volume":"15","author":"Boban","year":"2025","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-29054-w","article-title":"The urinary microbiome associated with bladder cancer","volume":"8","author":"Bu\u010devi\u0107 Popovi\u0107","year":"2018","journal-title":"Sci. Rep."},{"key":"B13","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.euo.2023.02.004","article-title":"Global meta-analysis of urine microbiome: colonization of polycyclic aromatic hydrocarbon\u2013degrading bacteria among bladder cancer patients","volume":"6","author":"Bukavina","year":"2023","journal-title":"Eur. Urol. Oncol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nrmicro.2017.157","article-title":"The human skin microbiome","volume":"16","author":"Byrd","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/nature25994","article-title":"Skin microbiota-host interactions (vol 553, pg 427, 2018)","volume":"553","author":"Chen","year":"2018","journal-title":"Nature"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-021-02407-8","article-title":"Urogenital microbiota:Potentially important determinant of PD-L1 expression in male patients with non-muscle invasive bladder cancer","volume":"22","author":"Chen","year":"2022","journal-title":"BMC Microbiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.urolonc.2020.04.014","article-title":"Characterization of urinary microbiome in patients with bladder cancer: Results from a single-institution, feasibility study","volume":"38","author":"Chipollini","year":"2020","journal-title":"Urologic Oncol. Semin. Original Investigations"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1177\/11795549231206796","article-title":"Is the urinary and gut microbiome associated with bladder cancer","volume":"17","author":"Chorbi\u0144ska","year":"2023","journal-title":"Clin. Med. Insights Oncol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ejogrb.2018.06.011","article-title":"Age, menopausal status and the bladder microbiome","volume":"228","author":"Curtiss","year":"2018","journal-title":"Eur. J. Obstet. Gynecol Reprod. Biol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1080\/17460913.2024.2414671","article-title":"Microbiome and bladder cancer: the role of probiotics in treatment","volume":"20","author":"Dadgar-Zankbar","year":"2024","journal-title":"Future Microbiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nrc3611","article-title":"Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms","volume":"13","author":"Elinav","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"B22","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int. J. Cancer"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-10-174","article-title":"Integrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injury","volume":"10","author":"Fouts","year":"2012","journal-title":"J. Transl. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1001\/jama.2011.1142","article-title":"Association between smoking and risk of bladder cancer among men and women","volume":"306","author":"Freedman","year":"2011","journal-title":"JAMA J. Am. Med. Assoc."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11040504","article-title":"Gastric microbiota in -negative and -positive gastritis among high incidence of gastric cancer area","volume":"11","author":"Gantuya","year":"2019","journal-title":"Cancers"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1506319","article-title":"Bladder cancer microbiome and its association with chemoresponse","volume":"15","author":"Ginwala","year":"2025","journal-title":"Front. Oncol."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/life13030812","article-title":"The urinary microbiome and bladder cancer","volume":"13","author":"Heidar","year":"2023","journal-title":"Life-Basel"},{"key":"B28","doi-asserted-by":"publisher","first-page":"22.e13","DOI":"10.1016\/j.urolonc.2023.11.003","article-title":"The bladder microbiota is not significantly altered by intravesical BCG therapy","volume":"42","author":"Heidrich","year":"2024","journal-title":"Urol. Oncol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.urology.2018.10.023","article-title":"Reduced recurrence of low-grade papillary bladder tumors associated with asymptomatic bacteriuria","volume":"124","author":"Herr","year":"2019","journal-title":"Urology"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-03292-x","article-title":"Alpha-diversity and microbial community structure of the male urinary microbiota depend on urine sampling method","volume":"11","author":"Hrbacek","year":"2021","journal-title":"Sci. Rep."},{"key":"B31","doi-asserted-by":"publisher","first-page":"107.e15","DOI":"10.1016\/j.urolonc.2022.09.018","article-title":"Bladder cancer is associated with decreased urinary microbiota diversity and alterations in microbial community composition","volume":"41","author":"Hrb\u00e1\u010dek","year":"2023","journal-title":"Urol. Oncol."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2019.1665973","article-title":"Antibiotic use and the efficacy of immune checkpoint inhibitors in cancer patients: a pooled analysis of 2740 cancer patients","volume":"8","author":"Huang","year":"2019","journal-title":"Oncoimmunology"},{"key":"B33","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41392-021-00544-0","article-title":"Extracellular matrix and its therapeutic potential for cancer treatment","volume":"6","author":"Huang","year":"2021","journal-title":"Signal. Transduct Tar"},{"key":"B34","doi-asserted-by":"publisher","first-page":"370.e9","DOI":"10.1016\/j.urolonc.2020.12.011","article-title":"Investigating the association between the urinary microbiome and bladder cancer: an exploratory study","volume":"39","author":"Hussein","year":"2021","journal-title":"Urologic Oncol. Semin. Original Investigations"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1125809","article-title":"Impact of intravesical Bacillus Calmette-Gu\u00e9rin and chemotherapy on the bladder microbiome in patients with non-muscle invasive bladder cancer","volume":"13","author":"James","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"19","DOI":"10.21037\/tau-2025-718","article-title":"Overview of tumor-resident intratumoral microbiota in human bladder cancer","volume":"15","author":"Jia","year":"2026","journal-title":"Transl. Androl Urol."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00212-24","article-title":"BCG therapy in bladder cancer and its tumor microenvironment interactions","volume":"38","author":"Jian","year":"2025","journal-title":"Clin. Microbiol. Rev."},{"key":"B38","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1038\/s41385-020-00372-5","article-title":"The microbiome and host mucosal interactions in urinary tract diseases","volume":"14","author":"Jones-Freeman","year":"2021","journal-title":"Mucosal Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1186\/s12866-025-04367-9","article-title":"Urinary microbiome in non-muscle invasive bladder cancer: impact of sample types and sex differences","volume":"25","author":"Kang","year":"2025","journal-title":"BMC Microbiol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s00345-021-03924-x","article-title":"Uncovering the role of urinary microbiota in urological tumors: a systematic review of literature","volume":"40","author":"Karam","year":"2022","journal-title":"World J. Urol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/1751-2980.12595","article-title":"Impact of Klebsiella pneumoniae in lower gastrointestinal tract diseases","volume":"19","author":"Kaur","year":"2018","journal-title":"J. Digestive Dis."},{"key":"B42","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat. Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"7","DOI":"10.14777\/uti.2018.13.1.7","article-title":"Lactobacillusand urine microbiome in association with urinary tract infections and bacterial vaginosis","volume":"13","author":"Kim","year":"2018","journal-title":"Urogenital Tract Infection"},{"key":"B44","doi-asserted-by":"publisher","first-page":"e725","DOI":"10.1097\/JU.0000000000002056.04","article-title":"PD42-04 Tumor microbiome associated with bcg response in non-muscle invasive bladder cancer","volume":"206","author":"Knorr","year":"2021","journal-title":"J. Urol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"291.e1","DOI":"10.1016\/j.urolonc.2024.04.011","article-title":"An exploratory study investigating the impact of the bladder tumor microbiome on Bacillus Calmette Guerin (BCG) response in non-muscle invasive bladder cancer","volume":"42","author":"Knorr","year":"2024","journal-title":"Urol. Oncol."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1097\/ju.0000000000002538.01","article-title":"PD12-01 bladder tumor microbiome may augment response to bcg in non-muscle invasive bladder cancer","volume":"207","author":"Knorr","year":"2022","journal-title":"J. Urol."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25031732","article-title":"The urinary microbiome in health and disease: relevance for bladder cancer","volume":"25","author":"Kustrimovic","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"B48","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nrurol.2013.153","article-title":"Toll-like receptors in urothelial cells-targets for cancer immunotherapy","volume":"10","author":"LaRue","year":"2013","journal-title":"Nat. Rev. Urol."},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2013.00041","article-title":"The human urinary microbiome; bacterial DNA in voided urine of asymptomatic adults","volume":"3","author":"Lewis","year":"2013","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11255-025-04607-x","article-title":"A cross-sectional study on the effects of intravesical BCG on urinary microbiota in bladder cancer patients","volume":"58","author":"Li","year":"2026","journal-title":"Int. Urol. Nephrol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"6904","DOI":"10.1002\/cam4.2419","article-title":"Dysbiosis signatures of the microbial profile in tissue from bladder cancer","volume":"8","author":"Liu","year":"2019","journal-title":"Cancer Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.prp.2018.05.010","article-title":"The prognostic values of tumor-infiltrating neutrophils, lymphocytes and neutrophil\/lymphocyte rates in bladder urothelial cancer","volume":"214","author":"Liu","year":"2018","journal-title":"Pathol. Res. Pract."},{"key":"B53","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41585-024-00910-x","article-title":"The bladder tumour microbiome and BCG response","volume":"21","author":"Lloyd","year":"2024","journal-title":"Nat. Rev. Urol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.cmi.2015.10.038","article-title":"(formerly): a newly recognized pathogen-review of the literature","volume":"22","author":"Lotte","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"key":"B55","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.maturitas.2013.10.018","article-title":"Estrogenic action on innate defense mechanisms in the urinary tract","volume":"77","author":"Luthje","year":"2014","journal-title":"Maturitas"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.677605","article-title":"Can smoking cause differences in urine microbiome in male patients with bladder cancer? A retrospective study","volume":"11","author":"Ma","year":"2021","journal-title":"Front. Oncol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/4824909","article-title":"Common core bacterial biomarkers of bladder cancer based on multiple datasets","volume":"2019","author":"Mai","year":"2019","journal-title":"BioMed. Res. Int."},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-67443-2","article-title":"Bladder cancer-related microbiota: examining differences in urine and tissue samples","volume":"10","author":"Mansour","year":"2020","journal-title":"Sci. Rep."},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024393","article-title":"Enhanced pro-inflammatory cytokine responses following Toll-like-receptor ligation in Schistosoma haematobium-infected schoolchildren from rural Gabon","volume":"6","author":"Meurs","year":"2011","journal-title":"PloS One"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252011157","article-title":"Differential urinary microbiome and its metabolic footprint in bladder cancer patients following BCG treatment","volume":"25","author":"Min","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"B61","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1128\/cmr.12.1.97","article-title":"Relationship between schistosomiasis and bladder cancer","volume":"12","author":"Mostafa","year":"1999","journal-title":"Clin. Microbiol. Rev."},{"key":"B62","doi-asserted-by":"publisher","first-page":"359","DOI":"10.2147\/rru.S233386","article-title":"Urinary microbiome evaluation in patients presenting with hematuria with a focus on exposure to tobacco smoke","volume":"11","author":"Moynihan","year":"2019","journal-title":"Res. Rep. Urol."},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-018-1379-1","article-title":"The effect of antimicrobial drug use on the composition of the genitourinary microbiota in an elderly population","volume":"19","author":"Mulder","year":"2019","journal-title":"BMC Microbiol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.21037\/atm-20-2976","article-title":"The human microbiome and genitourinary Malignancies","volume":"8","author":"Nicolaro","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"B65","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s44178-023-00064-7","article-title":"Role of signaling pathways in the interaction between microbial, inflammation and cancer","volume":"2","author":"Nwabo Kamdje","year":"2023","journal-title":"Holistic Integr. Oncol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/Ju.0000000000001336","article-title":"The microbiome of catheter collected urine in males with bladder cancer according to disease stage","volume":"205","author":"Oresta","year":"2021","journal-title":"J. Urol."},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.14193","article-title":"Urinary microbiota; which non-\u0131nvasive urine collection method should we use","volume":"75","author":"Ozer","year":"2021","journal-title":"Int. J. Clin. Pract."},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.718776","article-title":"Profiling the bladder microbiota in patients with bladder cancer","volume":"12","author":"Parra-Grande","year":"2022","journal-title":"Front. Microbiol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1093\/annonc\/mdz249.039","article-title":"A differential bladder microbiota composition is associated with tumour grade in bladder cancer","volume":"30","author":"Parra-Grande","year":"2019","journal-title":"Ann. Oncol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"e01283","DOI":"10.1128\/mBio.01283-14","article-title":"The female urinary microbiome: a comparison of women with and without urgency urinary incontinence","volume":"5","author":"Pearce","year":"2014","journal-title":"Mbio"},{"key":"B71","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.euo.2020.04.002","article-title":"Sex-specific alterations in the urinary and tissue microbiome in therapy-na\u00efve urothelial bladder cancer patients","volume":"3","author":"Pederzoli","year":"2020","journal-title":"Eur. Urol. Oncol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/s41585-018-0055-4","article-title":"Mechanisms of BCG immunotherapy and its outlook for bladder cancer","volume":"15","author":"Pettenati","year":"2018","journal-title":"Nat. Rev. Urol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"41","DOI":"10.5213\/inj.1938244.122","article-title":"The urine microbiome of healthy men and women differs by urine collection method","volume":"24","author":"Pohl","year":"2020","journal-title":"Int. Neurourol J."},{"key":"B74","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s13577-021-00659-0","article-title":"Deciphering the influence of urinary microbiota on FoxP3+\u2009regulatory T cell infiltration and prognosis in Chinese patients with non-muscle-invasive bladder cancer","volume":"35","author":"Qiu","year":"2022","journal-title":"Hum. Cell"},{"key":"B75","doi-asserted-by":"publisher","first-page":"4053","DOI":"10.3748\/wjg.v28.i30.4053","article-title":"Gut microbiota, inflammatory bowel disease and colorectal cancer","volume":"28","author":"Quaglio","year":"2022","journal-title":"World J. Gastroenterol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.euf.2014.11.001","article-title":"Smoking and bladder cancer: a systematic review of risk and outcomes","volume":"1","author":"Rink","year":"2015","journal-title":"Eur. Urol. Focus"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.22","article-title":"Bladder cancer","volume":"3","author":"Sanli","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"B78","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1186\/s12967-025-06518-y","article-title":"Exploring bladder cancer through urinary microbiota: innovative \"urinetypes\" classification and establishment of a diagnostic model","volume":"23","author":"Sheng","year":"2025","journal-title":"J. Transl. Med."},{"key":"B79","doi-asserted-by":"publisher","first-page":"121","DOI":"10.4103\/aam.aam_56_18","article-title":"Inflammation and cancer","volume":"18","author":"Singh","year":"2019","journal-title":"Ann. Afr. Med."},{"key":"B80","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s00345-024-05173-0","article-title":"A review of urinary bladder microbiome in patients with bladder cancer and its implications in bladder pathogenesis","volume":"42","author":"Stamatakos","year":"2024","journal-title":"World J. Urol."},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1038\/nrurol.2014.343","article-title":"Urinary tract infection increases risk","volume":"12","author":"Stone","year":"2014","journal-title":"Nat. Rev. Urol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"E123","DOI":"10.1016\/j.eururo.2016.01.055","article-title":"Reply to Stephen B. Williams and Ashish M. Kamat's Letter to the Editor re: Samantha Cambier, Richard J. Sylvester, Laurence Collette, et\u00a0al. EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guerin. Eur Urol 2016;69:60-9","volume":"69","author":"Sylvester","year":"2016","journal-title":"Eur. Urol."},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-026-04829-8","article-title":"Integrative multi-cohort analysis identifies urinary microbiota as non-invasive biomarkers of bladder cancer","volume":"26","author":"Tao","year":"2026","journal-title":"BMC Microbiol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1634\/theoncologist.2019-0160","article-title":"Cumulative antibiotic use significantly decreases efficacy of checkpoint inhibitors in patients with advanced cancer","volume":"25","author":"Tinsley","year":"2020","journal-title":"Oncologist"},{"key":"B85","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41571-023-00744-3","article-title":"Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice","volume":"20","author":"van Hoogstraten","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3390\/ijms251810159","article-title":"Dysbiosis in human urinary microbiota may differentiate patients with a bladder cancer","volume":"25","author":"Vendrell","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"B87","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1186\/s12967-024-05762-y","article-title":"Blautia coccoides and its metabolic products enhance the efficacy of bladder cancer immunotherapy by promoting CD8(+) T cell infiltration","volume":"22","author":"Wang","year":"2024","journal-title":"J. Transl. Med."},{"key":"B88","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.eururo.2015.02.041","article-title":"Sterile urine'' and the presence of bacteria","volume":"68","author":"Wolfe","year":"2015","journal-title":"Eur. Urol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/s13238-020-00813-8","article-title":"Unexpected guests in the tumor microenvironment: microbiome in cancer","volume":"12","author":"Wong-Rolle","year":"2021","journal-title":"Protein Cell"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2018.00167","article-title":"Profiling the urinary microbiota in male patients with bladder cancer in China","volume":"8","author":"Wu","year":"2018","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B91","first-page":"57","article-title":"Mini-review: perspective of the microbiome in the pathogenesis of urothelial carcinoma","volume":"2","author":"Xu","year":"2014","journal-title":"Am. J. Clin. Exp. Urol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.semcancer.2021.12.010","article-title":"Urinary microbiota and bladder cancer: a systematic review and a focus on uropathogens","volume":"86","author":"Yacouba","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.555508","article-title":"Alterations in urobiome in patients with bladder cancer and implications for clinical outcome: A single-institution study","volume":"10","author":"Zeng","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1002\/ijc.31959","article-title":"Fermented dairy foods intake and risk of cancer","volume":"144","author":"Zhang","year":"2018","journal-title":"Int. J. Cancer"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-023-02900-0","article-title":"Cancer-associated fibroblasts-derived CXCL12 enhances immune escape of bladder cancer through inhibiting P62-mediated autophagic degradation of PDL1","volume":"42","author":"Zhang","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1890640\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T12:01:43Z","timestamp":1787227303000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1890640\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":95,"alternative-id":["10.3389\/fcimb.2026.1890640"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2026.1890640","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]},"article-number":"1890640"}}